Probiotec Limited provides earnings guidance for the fiscal year 2018. The company announced that based on its unaudited financials for fiscal year 2018 it expects to report sales revenue to be $75.7 million, EBITDA to be in the range of $9.8 million to $10.2 million and NPAT to be in the range of $4.3 million to $4.6 million.